O

Oculis Holding AG
NASDAQ:OCS

Watchlist Manager
Oculis Holding AG
NASDAQ:OCS
Watchlist
Price: 17.63 USD 0.74% Market Closed
Market Cap: 917.8m USD

Net Margin
Oculis Holding AG

0%
Current
0%
Average
5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-102.9m
/
Revenue
0

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CH
Oculis Holding AG
NASDAQ:OCS
979.5m USD N/A
US
Eli Lilly and Co
NYSE:LLY
735.9B USD
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
404B USD
25%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
35%
CH
Roche Holding AG
SIX:ROG
202.1B CHF
14%
CH
Novartis AG
SIX:NOVN
178.4B CHF
25%
UK
AstraZeneca PLC
LSE:AZN
160.5B GBP
14%
US
Merck & Co Inc
NYSE:MRK
205.3B USD
27%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.9B USD
13%

Oculis Holding AG
Glance View

Market Cap
979.5m USD
Industry
Pharmaceuticals

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improve eye care. The company is headquartered in Zug, Zug and currently employs 28 full-time employees. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

OCS Intrinsic Value
Not Available
O
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-102.9m
/
Revenue
0
What is the Net Margin of Oculis Holding AG?

Based on Oculis Holding AG's most recent financial statements, the company has Net Margin of 0%.

Back to Top